About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 354979, 6 pages
http://dx.doi.org/10.1155/2012/354979
Review Article

Ocriplasmin for Vitreoretinal Diseases

Retina Division, Jules Stein Eye Institute, University of California, Los Angeles, CA 90095, USA

Received 27 March 2012; Accepted 6 June 2012

Academic Editor: Lindsey A. Miles

Copyright © 2012 Irena Tsui et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [16 citations]

The following is the list of published articles that have cited the current article.

  • Querques, Codenotti, Maestranzi, De Benedetto, and Bandello, “Reply to Matonti et al,” Eye (Basingstoke), vol. 27, no. 6, pp. 778, 2013. View at Publisher · View at Google Scholar
  • F Matonti, J C Courjaret, S Nadeau, and D Denis, “Comment on ‘Vitreomacular traction syndrome: a comparison of treatment with intravitreal plasmin enzyme vs spontaneous vitreous separation without treatment’,” Eye, vol. 27, no. 6, pp. 777–778, 2013. View at Publisher · View at Google Scholar
  • Lies De Groef, Inge Van Hove, Eline Dekeyster, Ingeborg Stalmans, and Lieve Moons, “MMPs in the Trabecular Meshwork: Promising Targets for Future Glaucoma Therapies?,” Investigative Ophthalmology & Visual Science, vol. 54, no. 12, pp. 7756–7763, 2013. View at Publisher · View at Google Scholar
  • Francesco Bandello, Carlo La Spina, and Maurizio Battaglia Parodi, “Management of macular edema from branch retinal vein occlusions,” Expert Review of Ophthalmology, vol. 8, no. 5, pp. 469–473, 2013. View at Publisher · View at Google Scholar
  • Carlo La Spina, Lorenzo Iuliano, Giovanni Fogliato, and Maurizio Battaglia Parodi, “Review and Perspectives on Pharmacological Vitreolysis,” Ophthalmologica, vol. 230, no. 4, pp. 179–185, 2013. View at Publisher · View at Google Scholar
  • Michael John Tolentino, Abrahan Dennrick, Elizabeth John, and Michael Steven Tolentino, “Drugs in Phase II clinical trials for the treatment of age-related macular degeneration,” Expert Opinion on Investigational Drugs, pp. 1–17, 2014. View at Publisher · View at Google Scholar
  • Jason Flamendorf, and Howard F. Fine, “Pharmacotherapy for Treatment and Prevention of Proliferative Diabetic Retinopathy,” Current Ophthalmology Reports, 2014. View at Publisher · View at Google Scholar
  • Francisco R. Stefanini, Maurício Maia, Paulo Falabella, Marcel Pfister, Moritz Niemeyer, Amir H. Kashani, Mark S. Humayun, and Michael J. Koss, “Profile of ocriplasmin and its potential in the treatment of vitreomacular adhesion,” Clinical Ophthalmology, vol. 8, pp. 847–856, 2014. View at Publisher · View at Google Scholar
  • Tzyy-Chang Ho, Chung-May Yang, Jen-Shang Huang, Chang-Hao Yang, and Muh-Shy Chen, “Foveola nonpeeling internal limiting membrane surgery to prevent inner retinal damages in early stage 2 idiopathic macula hole,” Graefe's Archive for Clinical and Experimental Ophthalmology, 2014. View at Publisher · View at Google Scholar
  • Craig Thelwell, “Biological Standards for Potency Assignment to Fibrinolytic Agents Used in Thrombolytic Therapy,” Seminars in Thrombosis and Hemostasis, vol. 40, no. 2, pp. 205–213, 2014. View at Publisher · View at Google Scholar
  • Mengyu Zhang, and Youxin Chen, “Research update of ocriplasmin for symptomatic vitreomacular adhesion,” Chinese Journal of Ophthalmology, vol. 50, no. 11, pp. 866–870, 2014. View at Publisher · View at Google Scholar
  • Christina Y. Weng, Jorge A. Fortun, Petros E. Carvounis, and Thomas A. Albini, “Ocriplasmin and its role in the management of vitreoretinal interface disorders,” International Ophthalmology Clinics, vol. 54, no. 2, pp. 29–38, 2014. View at Publisher · View at Google Scholar
  • Peter K. Kaiser, and Ashleigh L. Levison, “Vitreomacular interface diseases: Diagnosis and management,” Taiwan Journal of Ophthalmology, vol. 4, no. 2, pp. 63–68, 2014. View at Publisher · View at Google Scholar
  • Luxi Li, Hongjun Du, Manhong Li, and Yannian Hui, “Clinical evaluation of ocriplasmin as a vitreolytic agent,” Chinese Journal of Ophthalmology, vol. 51, no. 2, pp. 155–160, 2015. View at Publisher · View at Google Scholar
  • Katherine E. Talcott, Bobeck S. Modjtahedi, and Dean Eliott, “Surgical Management of Diabetic Macular Edema,” International Ophthalmology Clinics, vol. 55, no. 4, pp. 123–136, 2015. View at Publisher · View at Google Scholar
  • Chul Gu Kim, Hyoung Jun Koh, Hae Min Kang, Sung Jun Lee, and Eun Jee Chung, “Gas-mediated vitreomacular adhesion release with intravitral ranibizumab injections for exudative age-related macular degeneration,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 254, no. 9, pp. 1681–1692, 2016. View at Publisher · View at Google Scholar